Myriad Genetics Inc (MYGN)
- Exchange
- NASDAQ
- Symbol
- MYGN
- Sector
- Life Sciences
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Description
- Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company is headquartered in Salt Lake City, Utah.
- Country
- USA
Stock price
At close: October 21, 2025
-
Open7.93
-
High8.25
-
Low7.84
-
Close8.06
-
Volume792,685
Financial ratios
Dec 31, 2024